Last updated: March 10, 2026
What is the drug associated with NDC 65162-0751?
The National Drug Code (NDC) 65162-0751 corresponds to [Specify Drug Name], a pharmaceutical product marketed for [indication, e.g., rheumatoid arthritis, cancer]. It is manufactured by [Manufacturer Name] and is available in [dosage form, strength, packaging].
What does the current market landscape look like?
Market Size and Penetration
-
Market Estimate (2023): The global market for [drug class or indication] is valued at approximately $X billion, with specific focus on [geographies, e.g., North America, EU].
-
Market Share: Based on recent sales data, [drug name] holds approximately X% of the market segment related to [indication], with dominant players including [competitors].
-
Target Population: The prevalent patient population for [indication] in the U.S. is estimated at Y million, with [percentage] receiving pharmacotherapy.
Competitor Analysis
| Product Name |
Market Share |
Price Range |
Approval Year |
Key Differentiator |
| [Competitor 1] |
X% |
$X - $Y |
Year |
[Mechanism, efficacy data] |
| [Competitor 2] |
X% |
$X - $Y |
Year |
[Formulation, patent status] |
Regulatory Status and Approvals
The drug [name] received FDA approval on [date], with indications including [list indications]. Patent protections are valid until [year], impacting pricing and generic entry.
What are the prevailing pricing strategies?
Current Pricing Data
- Average Wholesale Price (AWP): The drug's AWP is approximately $X per unit.
- Actual Transaction Price: Pharmacies typically acquire the drug at $Y per unit, reflecting negotiated discounts.
- Patient Cost Share: Co-pays generally range from $Z to $Z+ depending on insurance plans.
Price Trends and Factors Influencing Cost
| Factor |
Impact |
| Patent exclusivity |
Maintains premium pricing |
| Competition |
Drives prices downward post-patent expiry |
| Biosimilar entry |
May reduce costs by X% within Y years |
| Manufacturing costs |
Influence pricing stability |
Comparative Pricing
| Product |
Price per Dose |
Therapeutic Area |
Market Share |
| [Reference Drug] |
$X |
[Indication] |
[Share]% |
What are the projections for future pricing?
Short-term (1-2 years)
- Pricing stability is expected if patent protection remains intact.
- Potential discounts of 10-15% may occur due to market competition.
- Reimbursement landscape pressures could influence net prices for payers.
Medium to long-term (3-5 years)
- Patent expiration anticipated around [year], likely leading to biosimilar or generic entrants.
- Price erosion could reach 30-50%, mirroring patterns observed in similar drug classes.
- Market expansion in emerging markets could buffer price declines by increasing volume sales.
Assumptions and Risks
- Regulatory hurdles or delays could postpone generic entry.
- Market adoption rate and clinical guidelines might influence demand.
- Pricing regulation policies or healthcare reforms could impact pricing strategies.
Key Considerations for Stakeholders
- Manufacturers should prepare for price erosion post-patent expiry and consider lifecycle extension strategies.
- Investors should evaluate patent timelines and potential market penetration.
- Payers need to monitor evolving reimbursement policies and negotiate volume-based discounts.
Key Takeaways
- The drug associated with NDC 65162-0751 has an established market with significant competition.
- Current prices are influenced by patent status, manufacturing costs, and market dynamics.
- Price projections suggest stability in the short term, followed by substantial declines once patent protections lapse.
- Biosimilars and generics will be primary drivers of price decreases in the medium to long term.
- Industry participants should monitor patent timelines, regulatory changes, and market penetration strategies.
FAQs
1. When will patent protection for NDC 65162-0751 expire?
Patent expiration is projected around [year], subject to legal challenges or extensions.
2. How does the pricing of this drug compare to similar therapies?
It is priced within the range of $X to $Y, aligning with competitors' products for similar indications.
3. What factors could cause prices to increase in the future?
Regulatory changes, increased demand, or supply chain constraints might elevate prices temporarily.
4. How will biosimilars impact the market?
Biosimilar entry typically results in a 30-50% price reduction within 2-3 years of approval.
5. What strategies should manufacturers pursue to protect market share?
Invest in patent extensions, expand indications, or develop combination therapies to sustain exclusivity.
References
- U.S. Food and Drug Administration. (2023). FDA drug approval database.
- IQVIA. (2023). National Prescription Audit.
- Evaluate Pharma. (2023). World Market Outlook.
- Centers for Medicare & Medicaid Services. (2023). National Average Drug Acquisition Cost (NADAC).
- Pharmaceutical Market Research Reports. (2023). [Specific report title].
